Related Experiment Video
Updated: May 26, 2025

10:27
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
7.2K
Anti-PD-1 treatment for MSI-H/MMRD tumors. A journey from genomics to transformative patient breakthroughs
G Argilés1, D Arnold2, A Cervantes3
1Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, U.S..
Abstract
No abstract available in PubMed .

